Healthcare · NSE: EMCURE
Emcure Pharmaceuticals Limited
₹1,875.00
-0.01% · close 28 Oct 2026
52-week range
₹1,318.90 – ₹2,009.60
From 52W high
-6.70%
Return 1Y
+41.40%
Volume · Avg 20D
62,133 · 1.12 L
Returns & technicals
1W+6.83%
1M-3.88%
3M-0.91%
6M+14.47%
1Y+41.40%
| 50-day average | ₹1,891.06 below |
| 200-day average | ₹1,720.01 above |
| Volatility (1Y, annualised) | 31.92% |
| RSI (14) | 52.0 |
| MACD histogram (12, 26, 9) | 2.51 |
| Delivery · 20D avg | 59.46% · 57.08% |
| Turnover (last day) | ₹12 Cr |
Profile
| Symbol | EMCURE |
| ISIN | INE168P01015 |
| Sector | Healthcare |
| Listed on NSE | 10 Jul 2024 |
| Face value | ₹10 |
| Series | EQ |
Financials & shareholding
Quarterly results and the shareholding pattern for EMCURE aren't available right now.
Peers in Healthcare
| Stock | Price | Day | 1M | 1Y |
|---|---|---|---|---|
| PPLPHARMA Piramal Pharma Limited | ₹232.80 | +17.15% | +10.69% | +15.19% |
| SYNGENE Syngene International Limited | ₹410.85 | +12.19% | +8.49% | -37.51% |
| ACUTAAS Acutaas Chemicals Limited | ₹3,710.00 | -2.20% | +13.37% | +116.38% |
| DIVISLAB Divi's Laboratories Limited | ₹9,558.50 | +0.56% | -0.63% | +48.46% |
| ONESOURCE Onesource Specialty Pharma Limited | ₹1,577.60 | -0.77% | -1.56% | -14.00% |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,137.00 | +4.43% | -8.46% | +3.25% |